Roger Pomerantz
CIK 1614936 · Chief Executive Officer · last filed 2025-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.22M
Companies
8
Total Filings
67
Lifetime Open-Market Net
-$19.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INDP | Director | — | $3.58 | — | $0 | 6 | 2025-06-11 |
| Viracta Therapeutics, Inc. (VIRX) Delisted | Director | 126,478 | $0.01 | $1.2K | $0 | 19 | 2024-11-27 |
| CONTRAFECT Corp (CFRX) Delisted | Chief Executive Officer | 800 | $0.05 | $40 | $992 | 7 | 2022-02-17 |
| Intec Pharma Ltd. (NTEC) Delisted | Director | — | $9.63 | — | $0 | 2 | 2020-07-17 |
| MCRB | President and CEO | 213,976 | $5.70 | $1.22M | -$19.58M | 27 | 2019-06-14 |
| Rubius Therapeutics, Inc. (RUBY) Delisted | Director | 100 | $0.08 | $8 | $2.3K | 2 | 2018-07-23 |
| CONTRAFECT Corp (CFRX.W) Delisted | Director | — | — | — | $0 | 1 | 2016-05-11 |
| CONTRAFECT Corp (CFRX.Z) Delisted | Director | — | — | — | $0 | 3 | 2015-05-06 |
Recent Filings · Page 2 of 7
67 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-18 | Viracta Therapeutics, Inc. (VIRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | Viracta Therapeutics, Inc. (VIRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-30 | INDP | Grant (A) | — | $0 | EDGAR |
| 2023-05-26 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +9,035 | $0 | EDGAR |
| 2023-02-28 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +9,034 | $0 | EDGAR |
| 2022-11-29 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +9,034 | $0 | EDGAR |
| 2022-10-03 | INDP | Grant (A) | — | $0 | EDGAR |
| 2022-08-29 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +9,034 | $0 | EDGAR |
| 2022-08-11 | Viracta Therapeutics, Inc. (VIRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | Viracta Therapeutics, Inc. (VIRX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.